HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PRADAXA Oral Pellets safely and effectively. See full prescribing information for PRADAXA Oral Pellets. PRADAXA (dabigatran etexilate) oral pellets Initial U.S. Approval: 2024 WARNING: (A) PREMATURE DISCONTINUATION OF PRADAXA
by JL STROHECKER 2024 Cited by 1Dabigatran (Pradaxa) is an orally administered direct thrombin inhibitor labeled for the Pradaxa [prescribing information]. Ridgefield, Conn.:
These highlights do not include all the information needed to use PRADAXA Capsules safely and effectively. See full prescribing information for PRADAXA Capsules. PRADAXA (dabigatran etexilate) capsules, for oral use Initial U.S. Approval: 2024 WARNING: (A) PREMATURE DISCONTINUATION OF PRADAXA INCREASES THE RISK OF
Pradaxa [Prescribing Information] (2024) Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield.
HIGHLIGHTS OF PRESCRIBING INFORMATION. These highlights do not include all the information needed to use PRADAXA Capsules safely and effectively. See full prescribing information for
PRADAXA safely and effectively. See full prescribing information for. PRADAXA. PRADAXA (dabigatran etexilate mesylate) capsules for oral use. Initial U.S.
See full prescribing information for PRADAXA. PRADAXA (dabigatran etexilate mesylate) capsules for oral use WARNING: DISCONTINUING PRADAXA IN PATIENTS WITHOUT ADEQUATE CONTINUOUS ANTICOAGULATION INCREASES RISK OF STROKE . See full prescribing information for complete boxed warning. Discontinuing PRADAXA places patients at an increased risk of
Announces Updates to Prescribing Information for Pradaxa (dabigatran Discontinuing PRADAXA in absence of adequate alternative anticoagulation
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PRADAXA safely and effectively. See full prescribing information for
Comments
SHOULD BE:
Andy had literally simply RELAYED all the various information.